Timothy Carmody, PhD
Behavioral medicine, including treatment of nicotine dependence, chronic pain, behavioral factors in coronary heart disease, and obesity/weight management.
Janine Cataldo, RN, PhD, FAAN
Understanding behaviors and cognitive and affective factors associated with tobacco use among older adults.
Benjamin Chaffee, DDS, MPH, PhD
Understand how behaviors, biological attributes, and social circumstances influence health and disease distributions, often inequitably, across populations.
Jing Cheng, MD, MS, PhD
Assessment of the impact of tobacco use on health outcomes and healthcare expenditures.
Robin Corelli, PharmD
Tobacco cessation education and training to estimate the impact of approaches for generating community pharmacy-based referrals to tobacco cessation telephone quitlines.
Kevin Delucchi, PhD
Statistical methods for analysis of quantitative data including clinical trials of treatments for smoking cessation.
Stuart Gansky, MS, DrPH
Oral health research, health disparities research, applied statistical analyses and related methodological issues.
Peter Ganz
Cardiovascular effects and potential harms of conventional, new and emerging tobacco products.
Stanton Glantz, PhD
Health effects of secondhand smoke (with particular emphasis on the cardiovascular system), health and economic effects of tobacco control policies, e-cigarettes, marijuana policy, smoking in movies.
Pages
Center Leadership
Stanton A. Glantz, PhD
Director, Center for Tobacco Research Control & Education
Pamela Ling, MD MPH
Fellowship Program Director
Joe Guydish, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Tobacco Control Program
Research Spotlight
An important component of any FDA regulation of tobacco products is an economic analysis of the regulation.